The Success Paradox: Thailand's dialysis policy evolution and implications for modality choice reforms.

IF 3.7 3区 医学 Q2 UROLOGY & NEPHROLOGY
Sarinya Boongird, Talerngsak Kanjanabuch, Jeerath Phannajit, Piyatida Chuengsaman, Jadej Thammatacharee, Vuddhidej Ophascharoensuk
{"title":"The Success Paradox: Thailand's dialysis policy evolution and implications for modality choice reforms.","authors":"Sarinya Boongird, Talerngsak Kanjanabuch, Jeerath Phannajit, Piyatida Chuengsaman, Jadej Thammatacharee, Vuddhidej Ophascharoensuk","doi":"10.1177/08968608261443580","DOIUrl":null,"url":null,"abstract":"<p><p>Thailand's peritoneal dialysis (PD) policy evolution illustrates how apparent policy success can mask underlying system vulnerabilities. Between 2008 and 2021, Thailand's PD-First policy under the Universal Coverage Scheme (UCS) became an international model, expanding PD utilization from 2760 to over 25,000 patients while maintaining outcomes comparable to global benchmarks. In February 2022, the 2022 Policy removed PD-First restrictions to enhance patient choice. Within 3 years, PD utilization among incident UCS patients declined from 50% to 14%, 90-day mortality risk rose from 9% to 13%, and dialysis expenditures increased to 12% of the total UCS budget. These outcomes prompted the 2025 Reform in April 2025, following a review commissioned by the National Health Security Office and conducted by the Health Intervention and Technology Assessment Program (HITAP), with expert input from the Nephrology Society of Thailand (NST) and other stakeholders. Using aggregated national registry data across three periods-the PD-First period (2008-2021), the 2022 Policy period (2022-2024), and the 2025 Reform period (2025)-we examined utilization patterns, clinical outcomes, and fiscal impacts associated with these transitions. The temporal patterns suggest that rapid policy liberalization may expose and amplify existing capacity imbalances. Following the 2022 transition, utilization shifted toward existing hemodialysis infrastructure despite inadequate vascular surgery capacity, coinciding with reduced rates of permanent access and increased early mortality. Preliminary post-reform data show encouraging recovery, with 90-day mortality risk falling to 7%. Thailand's experience may inform countries expanding home dialysis through policy reforms, highlighting that sustainable choice requires sequenced policy liberalization, infrastructure capacity alignment, and responsive governance to maintain dialysis quality, equity, and fiscal stability.</p>","PeriodicalId":19969,"journal":{"name":"Peritoneal Dialysis International","volume":" ","pages":"8968608261443580"},"PeriodicalIF":3.7000,"publicationDate":"2026-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Peritoneal Dialysis International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08968608261443580","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Thailand's peritoneal dialysis (PD) policy evolution illustrates how apparent policy success can mask underlying system vulnerabilities. Between 2008 and 2021, Thailand's PD-First policy under the Universal Coverage Scheme (UCS) became an international model, expanding PD utilization from 2760 to over 25,000 patients while maintaining outcomes comparable to global benchmarks. In February 2022, the 2022 Policy removed PD-First restrictions to enhance patient choice. Within 3 years, PD utilization among incident UCS patients declined from 50% to 14%, 90-day mortality risk rose from 9% to 13%, and dialysis expenditures increased to 12% of the total UCS budget. These outcomes prompted the 2025 Reform in April 2025, following a review commissioned by the National Health Security Office and conducted by the Health Intervention and Technology Assessment Program (HITAP), with expert input from the Nephrology Society of Thailand (NST) and other stakeholders. Using aggregated national registry data across three periods-the PD-First period (2008-2021), the 2022 Policy period (2022-2024), and the 2025 Reform period (2025)-we examined utilization patterns, clinical outcomes, and fiscal impacts associated with these transitions. The temporal patterns suggest that rapid policy liberalization may expose and amplify existing capacity imbalances. Following the 2022 transition, utilization shifted toward existing hemodialysis infrastructure despite inadequate vascular surgery capacity, coinciding with reduced rates of permanent access and increased early mortality. Preliminary post-reform data show encouraging recovery, with 90-day mortality risk falling to 7%. Thailand's experience may inform countries expanding home dialysis through policy reforms, highlighting that sustainable choice requires sequenced policy liberalization, infrastructure capacity alignment, and responsive governance to maintain dialysis quality, equity, and fiscal stability.

成功悖论:泰国透析政策的演变及其对模式选择改革的影响。
泰国腹膜透析(PD)政策的演变说明了表面上的政策成功如何掩盖了潜在的系统脆弱性。2008年至2021年间,泰国在全民覆盖计划(UCS)下的PD优先政策成为国际典范,将PD利用率从2760例扩大到超过25,000例,同时保持与全球基准相当的结果。2022年2月,2022年政策取消了PD-First限制,以增强患者的选择。3年内,UCS患者的PD使用率从50%下降到14%,90天死亡风险从9%上升到13%,透析支出增加到UCS总预算的12%。这些结果促使2025年4月在国家卫生安全办公室委托进行审查并由卫生干预和技术评估计划(HITAP)进行审查之后,在泰国肾脏病学会(NST)和其他利益攸关方的专家意见下进行了2025年改革。使用三个时期的汇总国家注册数据- PD-First期(2008-2021),2022年政策期(2022-2024)和2025年改革期(2025)-我们检查了与这些过渡相关的使用模式,临床结果和财政影响。时间模式表明,迅速的政策自由化可能暴露和扩大现有的能力不平衡。在2022年过渡之后,尽管血管手术能力不足,但利用转向了现有的血液透析基础设施,与此同时,永久获得率下降,早期死亡率上升。改革后的初步数据显示复苏令人鼓舞,90天死亡率风险降至7%。泰国的经验可以为通过政策改革扩大家庭透析的国家提供借鉴,强调可持续选择需要有序的政策自由化、基础设施能力调整和响应性治理,以保持透析质量、公平和财政稳定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Peritoneal Dialysis International
Peritoneal Dialysis International 医学-泌尿学与肾脏学
CiteScore
6.00
自引率
17.90%
发文量
69
审稿时长
6-12 weeks
期刊介绍: Peritoneal Dialysis International (PDI) is an international publication dedicated to peritoneal dialysis. PDI welcomes original contributions dealing with all aspects of peritoneal dialysis from scientists working in the peritoneal dialysis field around the world. Peritoneal Dialysis International is included in Index Medicus and indexed in Current Contents/Clinical Practice, the Science Citation Index, and Excerpta Medica (Nephrology/Urology Core Journal). It is also abstracted and indexed in Chemical Abstracts (CA), as well as being indexed in Embase as a priority journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书